• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚一般实践患者或有动脉血栓形成风险患者的 REACH 登记处的结果。

Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis.

机构信息

CCRE Therapeutics, Monash University, Melbourne, VIC, Australia.

出版信息

Med J Aust. 2012 Feb 20;196(3):193-7. doi: 10.5694/mja11.10731.

DOI:10.5694/mja11.10731
PMID:22339526
Abstract

OBJECTIVE

To report on 1-year cardiovascular (CV) event rates in patients with established cardiovascular disease (CVD) or with multiple cardiovascular risk factors.

DESIGN, PATIENTS AND SETTING: Prospective cohort study of 2873 patients at high risk of atherothrombosis based on the presence of multiple risk factors and overt coronary artery disease (CAD), cerebrovascular disease (CerVD) or peripheral arterial disease (PAD) presenting to 273 Australian general practitioners; this study was conducted as part of the international REACH Registry.

MAIN OUTCOME MEASURES

One-year rates of cardiovascular death, myocardial infarction, stroke, and hospitalisation for cardiovascular procedures.

RESULTS

The cardiovascular death rate at 1 year was 1.4%. The combined cardiovascular death, non-fatal MI, stroke and hospitalisation rate for vascular disease affecting one location at 1 year was 11%. Even for patients with no overt disease, but with multiple risk factors, the 1-year combined event rate was 4.2%. The highest combined event rate was in patients with PAD (21.0%), and in patients with atherothrombotic disease identified in all three locations (coronary arteries, cerebrovascular system and peripheral arteries) at 39%.

CONCLUSION

The rate of clinical events in community-based patients with stable atherothrombotic disease increases dramatically with the severity of disease and the number of vascular beds involved. Where disease was evident in all three locations, and for patients with PAD alone, the 1-year risk of cardiovascular events was substantially increased. Poor adherence to statin therapy in the secondary preventive setting is a major treatment gap that needs to be closed; the influences of obesity and diabetes warrant further investigation.

摘要

目的

报告患有已确诊心血管疾病(CVD)或存在多种心血管危险因素患者的 1 年心血管(CV)事件发生率。

设计、患者和设置:对 273 名澳大利亚全科医生就诊的 2873 名高动脉粥样硬化血栓形成风险患者(基于存在多种危险因素和明显冠状动脉疾病(CAD)、脑血管疾病(CerVD)或外周动脉疾病(PAD))进行前瞻性队列研究;这项研究是国际 REACH 登记研究的一部分。

主要观察指标

心血管死亡、心肌梗死、卒中和心血管程序住院的 1 年发生率。

结果

1 年时心血管死亡率为 1.4%。1 年时,影响一个部位的心血管死亡、非致死性心肌梗死、卒中和血管疾病住院的复合发生率为 11%。即使对于没有明显疾病但存在多种危险因素的患者,1 年的复合事件发生率也为 4.2%。PAD 患者的复合事件发生率最高(21.0%),在冠状动脉、脑血管系统和外周动脉三个部位均存在动脉粥样硬化血栓形成疾病的患者中,复合事件发生率最高(39%)。

结论

在稳定的动脉粥样硬化血栓形成疾病的社区患者中,临床事件的发生率随着疾病的严重程度和受累血管床数量的增加而显著增加。在三个部位均存在疾病的情况下,以及 PAD 患者中,1 年心血管事件的风险显著增加。在二级预防环境中他汀类药物治疗的依从性差是一个主要的治疗差距,需要加以解决;肥胖和糖尿病的影响值得进一步研究。

相似文献

1
Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis.澳大利亚一般实践患者或有动脉血栓形成风险患者的 REACH 登记处的结果。
Med J Aust. 2012 Feb 20;196(3):193-7. doi: 10.5694/mja11.10731.
2
REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year.REACH:动脉粥样硬化血栓形成事件风险患者的国际前瞻性观察性注册研究。法国队列在基线和一年时的结果。
Arch Cardiovasc Dis. 2008 Feb;101(2):81-8. doi: 10.1016/s1875-2136(08)70263-8.
3
One-year cardiovascular event rates in outpatients with atherothrombosis.动脉粥样硬化血栓形成门诊患者的一年心血管事件发生率。
JAMA. 2007 Mar 21;297(11):1197-206. doi: 10.1001/jama.297.11.1197.
4
[Cardiovascular complications at 1-year of follow-up in patients with atherothrombosis. On behalf of Spain's REACH Registry].[动脉粥样硬化血栓形成患者随访1年时的心血管并发症。代表西班牙REACH注册研究]
Med Clin (Barc). 2009 Apr 18;132(14):537-44. doi: 10.1016/j.medcli.2008.11.033.
5
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.脑血管病和其他血管部位动脉粥样硬化血栓形成患者的心血管事件发生率:日本 REACH 登记研究 1 年结果。
J Neurol Sci. 2009 Dec 15;287(1-2):45-51. doi: 10.1016/j.jns.2009.09.011. Epub 2009 Oct 7.
6
Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).患有和不患有动脉粥样血栓形成的糖尿病和非糖尿病患者的心血管事件发生率(来自持续健康的动脉粥样血栓形成减少[REACH]登记册)。
Am J Cardiol. 2010 Mar 1;105(5):667-71. doi: 10.1016/j.amjcard.2009.10.048.
7
Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.老年非ST段抬高型心肌梗死患者的多血管疾病与长期心血管结局
Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):541-9. doi: 10.1161/CIRCOUTCOMES.111.964379. Epub 2012 Jun 19.
8
Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry.法国 COMPASS 入组患者的临床特征和结局。REACH 注册研究分析。
Ann Cardiol Angeiol (Paris). 2020 Oct;69(4):158-166. doi: 10.1016/j.ancard.2020.07.002. Epub 2020 Aug 7.
9
Two-year vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registry.症状性脑血管病患者的两年血管事件发生率:REACH 登记研究。
Cerebrovasc Dis. 2011;32(3):254-60. doi: 10.1159/000328650. Epub 2011 Aug 26.
10
[One-year data from the REACH registry in Spain].[来自西班牙REACH注册研究的一年期数据]
Med Clin (Barc). 2009 Sep;132 Suppl 2:10-4. doi: 10.1016/S0025-7753(09)71746-4.

引用本文的文献

1
Saving Legs & Lives: the efficacy of a community-based cardiovascular rehabilitation programme versus usual care on exercise capacity and quality of life in patients who have undergone lower limb revascularisation for peripheral arterial disease-protocol for a single-centre randomised-controlled trial.拯救双腿与生命:一项基于社区的心血管康复计划与常规护理对因外周动脉疾病接受下肢血管重建术患者运动能力和生活质量影响的单中心随机对照试验方案
BMJ Open. 2024 Dec 5;14(12):e089203. doi: 10.1136/bmjopen-2024-089203.
2
The use of a novel toe-thumb pressure index for assessing arterial status in the lower limb. A reliability and validity study.新型足趾-拇指压力指数用于评估下肢动脉状态的研究。一项可靠性和有效性研究。
J Foot Ankle Res. 2024 Dec;17(4):e70011. doi: 10.1002/jfa2.70011.
3
Radiation dose in coronary angiography and intervention: initial results from the establishment of a multi-centre diagnostic reference level in Queensland public hospitals.冠状动脉造影和介入治疗中的辐射剂量:昆士兰公立医院建立多中心诊断参考水平的初步结果
J Med Radiat Sci. 2014 Sep;61(3):135-41. doi: 10.1002/jmrs.67. Epub 2014 Aug 4.
4
The association of visceral adiposity with cardiovascular events in patients with peripheral artery disease.外周动脉疾病患者内脏脂肪与心血管事件的关联。
PLoS One. 2013 Dec 27;8(12):e82350. doi: 10.1371/journal.pone.0082350. eCollection 2013.
5
Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study.脂蛋白(a)与冠心病、脑血管病和外周动脉疾病风险:EPIC-Norfolk 前瞻性人群研究。
Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3058-65. doi: 10.1161/ATVBAHA.112.255521. Epub 2012 Oct 11.